Primary objective of the study is to determine the extent that offering of self-sampling in addition to clinician-sampling Human Papillomavirus (HPV) DNA testing will increase detection of HPV DNA through an increase in uptake rates of cervical cancer screening as compared to offering clinician-sampling HPV DNA testing alone.
The hypothesis is that offering additional self-sampling will increase the detection of high-risk HPV DNA by at least 7.7%.
30-69 years old female Singapore citizens
Due for cervical cancer screening
Engaged in sexual intercourse before
Able to give informed consent
Virgo intacta
Pregnancy
History of cervical cancer, precancerous cervical lesions and total hysterectomy
National Healthcare Group Polyclinics
Lead sponsor
National Healthcare Group, Singapore
Collaborator
KK Women's and Children's Hospital
Collaborator